{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:03:22Z","timestamp":1793829802492,"version":"4.6.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jchromb.2025.124530","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:09:13Z","timestamp":1739984953000},"page":"124530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A comprehensive evaluation of a bioanalytical technique for Encorafenib and Cetuximab combination Cancer therapy by LC-MS\/MS and their pharmacokinetics in plasma"],"prefix":"10.1016","volume":"1255","author":[{"given":"Anoop","family":"Bodapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangaraiah","family":"Pagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha Divya Madhuri","family":"Kallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124530_bb0005","series-title":"Handbook of LC\u2013MS Bioanalysis. Best Practices, Experimental Protocols and Regulations","author":"Wenkui","year":"2013"},{"key":"10.1016\/j.jchromb.2025.124530_bb0010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2014a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2025.124530_bb0015","series-title":"LC-MS in Drug Bioanalysis","year":"2012"},{"key":"10.1016\/j.jchromb.2025.124530_bb0020","series-title":"Principles and Practice of Bioanalysis","author":"Venn","year":"2008"},{"key":"10.1016\/j.jchromb.2025.124530_bb0030","unstructured":"GENE, BRAF. BRAF B-Raf proto-oncogene, serine\/threonine kinase [Homo sapiens (human)]-gene-NCBI. Retrieved May 5 (2015): 2019."},{"key":"10.1016\/j.jchromb.2025.124530_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1358\/dot.2005.41.2.882662","article-title":"Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody","volume":"41.2","author":"Harding","year":"2005","journal-title":"Drugs of today (Barcelona, Spain: 1998)"},{"issue":"6","key":"10.1016\/j.jchromb.2025.124530_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clinthera.2005.06.003","article-title":"Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer","volume":"27","author":"Wong","year":"2005","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124530_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jchromb.2025.124530_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115594","article-title":"Development and validation of an LC\u2013MS\/MS method to measure the BRAF inhibitors dabrafenib and encorafenib quantitatively and four major metabolites semi-quantitatively in human plasma","volume":"234","author":"Myszkiewicz","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jchromb.2025.124530_bb0055","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/molecules26092717","article-title":"A validated lc\u2013ms\/ms assay for the simultaneous quantification of the fda-approved anticancer mixture (Encorafenib and binimetinib): metabolic stability estimation","volume":"26","author":"Attwa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2025.124530_bb0060","first-page":"184","article-title":"RP-HPLC method development & validation for the simultaneous estimation of encorafenib and binimetinib in API & tablet dosage form","volume":"8","author":"Suroor","year":"2019","journal-title":"IJSR.NET."},{"key":"10.1016\/j.jchromb.2025.124530_bb0065","doi-asserted-by":"crossref","unstructured":"Raveendranath, Taduvai Venkata, Rajaiah Thangaraj Saravanakumar, and Anjana Male. Stability-indicating reversed phase-ultra performance liquid chromatography method development and validation for simultaneous determination of Encorafenib and Binimetinib in formulation. IJPSDR 12.5 (2020) 488\u2013494. DOI:10.25004\/IJPSDR.2020.120509.","DOI":"10.25004\/IJPSDR.2020.120509"},{"key":"10.1016\/j.jchromb.2025.124530_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121988","article-title":"Development and validation of a rapid RP-HPLC method for simultaneous quantification of paclitaxel and cetuximab in immuno liposomes","volume":"225","author":"de Souza","year":"2021","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.jchromb.2025.124530_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1039\/b9ay00027e","article-title":"The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum","volume":"1","author":"Hantash","year":"2009","journal-title":"Anal. Methods"},{"issue":"1","key":"10.1016\/j.jchromb.2025.124530_bb0080","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/s41598-017-02821-x","article-title":"A simple and rapid LC-MS\/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients","volume":"7","author":"Becher","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2025.124530_bb0085","series-title":"bioanalytical method validation\u2014guidance for industry, Food and Drug Administration","first-page":"20","year":"2018"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T21:04:14Z","timestamp":1741035854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":16,"alternative-id":["S1570023225000820"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124530","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive evaluation of a bioanalytical technique for Encorafenib and Cetuximab combination Cancer therapy by LC-MS\/MS and their pharmacokinetics in plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124530"}}